Volition to Take Part in Nu.Q® Vet Commercial Strategy Webinar

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison...

Related Keywords

London ,City Of ,United Kingdom ,Singapore ,Belgium ,Louise Batchelor Debra Daglish ,Soo Romanoff ,Heather Wilson Robles ,Tom Butera ,Healthcare At Edison Group ,Exchange Commission ,Securities Exchange ,Volition Veterinary Diagnostics Development ,Prnewswire Volitionrx Limited ,Edison Group ,Chief Executive Officer ,Chief Medical Officer ,Gael Forterre ,Chief Commercial ,Managing Director ,Vet Commercial ,Vet Cancer Test ,Vet Commercial Strategy ,Debra Daglish ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,Volitionrx Limited ,